# Zhejiang Hisun Pharmaceutical Co., Ltd. - Inspection Records

Source: https://www.keypedia.com/companies/zhejiang-hisun-pharmaceutical-co-ltd/38a26f64-d8df-4781-8322-3606f62da25d

> Inspection records and compliance data for Zhejiang Hisun Pharmaceutical Co., Ltd. in Taizhou, None. Access full analysis and detailed observations.

---

## Details

- Name: Zhejiang Hisun Pharmaceutical Co., Ltd.
- FEI Number: 3007719313
- City: Taizhou
- State: None
- Country Name: China
- Address Line 1: 46 Waisha Rd., Jiaojiang District
- Zip Code: None
- Facility Type: API/Finished Drug Product Manufacturer
- Business Operations: API MANUFACTURE, FDF MANUFACTURE

## Related Documents

- [FDA Inspection 1238621 - Zhejiang Hisun Pharmaceutical Co., Ltd. - 2024-06-21](https://www.keypedia.com/records/fda_inspections/zhejiang-hisun-pharmaceutical-co-ltd/f6ce3ffd-e027-48bf-bfdf-4f3879aa15f2) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 21, 2024
- [EMA GMP - Zhejiang Hisun Pharmaceutical Co., Ltd. - INS/GMP/2018/111; INS/GMP/2018/112; INS/GMP/2019/063 and INS/GMP/2019/064 - 2022-04-19](https://www.keypedia.com/records/ema/zhejiang-hisun-pharmaceutical-co-ltd/af958589-e931-44bd-9f0d-7851c5e1d6d3) — source: EMA, date: April 19, 2022
- [483 - Zhejiang Hisun Pharmaceutical Co., Ltd. - 2019-06-07](https://www.keypedia.com/records/483/zhejiang-hisun-pharmaceutical-co-ltd/43ac2a52-29ad-4d11-b102-c322a0e8e66b) — source: FDA, date: June 7, 2019
- [FDA Inspection 1096299 - Zhejiang Hisun Pharmaceutical Co., Ltd. - 2019-06-07](https://www.keypedia.com/records/fda_inspections/zhejiang-hisun-pharmaceutical-co-ltd/173f8cb1-f958-4ffe-ae3c-9ff0d8830ef2) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 7, 2019
- [483 - Zhejiang Hisun Pharmaceutical Co., Ltd. - 2017-08-11](https://www.keypedia.com/records/483/zhejiang-hisun-pharmaceutical-co-ltd/79173a11-bcaa-4b81-8e6b-2662fd1b9d1a) — source: FDA, date: August 11, 2017
- [FDA Inspection 1027076 - Zhejiang Hisun Pharmaceutical Co., Ltd. - 2017-08-11](https://www.keypedia.com/records/fda_inspections/zhejiang-hisun-pharmaceutical-co-ltd/628b40d4-2701-4654-b291-709cbf0dfd0c) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 11, 2017
- [483 - Zhejiang Hisun Pharmaceutical Co., Ltd. - 2017-08-07](https://www.keypedia.com/records/483/zhejiang-hisun-pharmaceutical-co-ltd/782a5325-2b6a-4fd5-a558-9bd88056c204) — source: FDA, date: August 7, 2017
- [483 - Zhejiang Hisun Pharmaceutical Co., Ltd. - 2017-01-19](https://www.keypedia.com/records/483/zhejiang-hisun-pharmaceutical-co-ltd/5bce805f-5cef-44fe-bc93-6f7b46060574) — source: FDA, date: January 19, 2017
- [FDA Inspection 998186 - Zhejiang Hisun Pharmaceutical Co., Ltd. - 2017-01-19](https://www.keypedia.com/records/fda_inspections/zhejiang-hisun-pharmaceutical-co-ltd/298ff408-5db4-463e-a0f2-e1b4d261a186) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 19, 2017
- [483 - Zhejiang Hisun Pharmaceutical Co., Ltd. - 2017-01-16](https://www.keypedia.com/records/483/zhejiang-hisun-pharmaceutical-co-ltd/52384d3b-e571-4eb3-93bb-9eb3742f8b98) — source: FDA, date: January 16, 2017
- [WARNING_LETTER - Zhejiang Hisun Pharmaceutical Co., Ltd. - 2015-03-07](https://www.keypedia.com/records/warning_letter/zhejiang-hisun-pharmaceutical-co-ltd/1c80aaa0-7c21-48ef-8a73-80a5561a3e9f) — source: FDA, date: March 7, 2015
- [FDA Inspection 918008 - Zhejiang Hisun Pharmaceutical Co., Ltd. - 2015-03-07](https://www.keypedia.com/records/fda_inspections/zhejiang-hisun-pharmaceutical-co-ltd/7d5d3246-ba28-4a79-aae1-fbd352e18a7f) — classification: Official Action Indicated (OAI), source: FDA, date: March 7, 2015
- [FDA Inspection 918008 - Zhejiang Hisun Pharmaceutical Co., Ltd. - 2015-03-07](https://www.keypedia.com/records/fda_inspections/zhejiang-hisun-pharmaceutical-co-ltd/4b8ef772-c6a9-48f6-9b5a-7e135ff81fb4) — classification: Official Action Indicated (OAI), source: FDA, date: March 7, 2015
- [FDA Inspection 794437 - Zhejiang Hisun Pharmaceutical Co., Ltd. - 2012-07-19](https://www.keypedia.com/records/fda_inspections/zhejiang-hisun-pharmaceutical-co-ltd/898d790f-e12d-4b9f-92cd-671080ded110) — classification: No Action Indicated (NAI), source: FDA, date: July 19, 2012
- [FDA Inspection 794531 - Zhejiang Hisun Pharmaceutical Co., Ltd. - 2012-07-19](https://www.keypedia.com/records/fda_inspections/zhejiang-hisun-pharmaceutical-co-ltd/47bcf70f-774a-4330-8492-ffa2b0cd540e) — classification: No Action Indicated (NAI), source: FDA, date: July 19, 2012
- [FDA Inspection 793692 - Zhejiang Hisun Pharmaceutical Co., Ltd. - 2012-07-19](https://www.keypedia.com/records/fda_inspections/zhejiang-hisun-pharmaceutical-co-ltd/cbe96857-716b-476b-8128-9dfe2f862a45) — classification: No Action Indicated (NAI), source: FDA, date: July 19, 2012
- [FDA Inspection 793692 - Zhejiang Hisun Pharmaceutical Co., Ltd. - 2012-07-19](https://www.keypedia.com/records/fda_inspections/zhejiang-hisun-pharmaceutical-co-ltd/17c50e77-ade6-41d1-9294-2857d56d0e2a) — classification: No Action Indicated (NAI), source: FDA, date: July 19, 2012

## Related Companies

- [Marcus Research Laboratory, Inc.](https://www.keypedia.com/companies/marcus-research-laboratory-inc/6ed62b27-3200-4374-b004-ec4c541dc0d9)
- [Morton Salt Inc](https://www.keypedia.com/companies/morton-salt-inc/823fa877-7377-4020-9234-37328296eec4)
- [Kyowa Hakko Bio Co., Ltd.](https://www.keypedia.com/companies/kyowa-hakko-bio-co-ltd/4ab0756a-78b6-4060-8087-809db6e7941b)
- [Fukuzyu Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/fukuzyu-pharmaceutical-co-ltd/3877ef0e-8f5d-4826-a235-7e04748254de)
- [Piramal Pharma Limited](https://www.keypedia.com/companies/piramal-pharma-limited/c2aa1ac8-a474-4948-84c1-cd848c50558e)
- [Cayman Chemical Company, Inc.](https://www.keypedia.com/companies/cayman-chemical-company-inc/8a9655d6-3cec-4e6e-836e-17e9659f3e5b)
- [Yuki Gosei Kogyo Co., Ltd.](https://www.keypedia.com/companies/yuki-gosei-kogyo-co-ltd/94411f09-2744-47ca-9250-20774e61824e)
- [Alps Pharmaceutical Industrial Co., Ltd.](https://www.keypedia.com/companies/alps-pharmaceutical-industrial-co-ltd/b7368086-4ecc-4cbe-b942-494bb1340c79)
- [DDP Specialty Electronic Materials US 9, LLC](https://www.keypedia.com/companies/ddp-specialty-electronic-materials-us-9-llc/bfd7705b-0b03-4c4e-a3d7-d0940e04a868)
- [Specialty Minerals, Inc.](https://www.keypedia.com/companies/specialty-minerals-inc/fa1116ce-bf42-40c1-b849-1d18b36fdd72)

## Related Officers

- [Thomas J. Cosgrove](https://www.keypedia.com/people/thomas-j-cosgrove/616abec3-5ed9-42aa-9f5d-392b5552b695)
- [Lindsey M. Schwaigerjohann](https://www.keypedia.com/people/lindsey-m-schwaigerjohann/9cff2b61-0816-4d65-b90f-ed9c892b76f4)
- [President](https://www.keypedia.com/people/peter-e-baker/c32eb848-de28-4725-80c9-ef8548d445bf)
- [Investigator ](https://www.keypedia.com/people/lindsey-schwierjohann/3608e7c0-5bb9-49f0-844d-ddd6f6724fdb)